Stay updated on SG + Pembrolizumab in HR+ / HER2- MBC Clinical Trial

Sign up to get notified when there's something new on the SG + Pembrolizumab in HR+ / HER2- MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SG + Pembrolizumab in HR+ / HER2- MBC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page adds a Locations section listing study sites in Georgia, Illinois, Massachusetts, North Carolina, and Pennsylvania, and removes the prior state-location entries; the revision tag updates from v3.3.2 to v3.3.3.
    Difference
    0.6%
    Check dated 2025-12-23T21:50:53.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Revision tag updated from v3.2.0 to v3.3.2 on the study page. No substantive changes to study details or eligibility criteria are evident.
    Difference
    0.0%
    Check dated 2025-11-25T11:41:15.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    A government funding status notice has been removed from the page; core study details, eligibility criteria, locations, and outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:12:32.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Results from the study have been posted on the page, and the study record dates show updates including 'Results First Posted' on 2025-05-30 and the latest update on 2025-06-25.
    Difference
    0.4%
    Check dated 2025-11-03T21:13:43.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Major update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T05:49:22.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a new version without other substantive content changes.
    Difference
    0.1%
    Check dated 2025-09-29T03:10:16.000Z thumbnail image

Stay in the know with updates to SG + Pembrolizumab in HR+ / HER2- MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SG + Pembrolizumab in HR+ / HER2- MBC Clinical Trial page.